| Bioactivity | Zicronapine is an antipsychotic medication with a strong pro-cognitive effect in animal models and the potential to treat a number of neurological and psychiatric diseases. Zicronapine has potent antagonistic effects at dopamine D1/D2, and serotonin 5-HT2A receptors. |
| Name | Zicronapine |
| CAS | 170381-16-5 |
| Formula | C22H27ClN2 |
| Molar Mass | 354.92 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Lopez De Diego, Heidi. et al. Succinate and malonate salts of trans-4-(1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and their preparation, pharmaceutical compositions, and use as medicaments, particularly as antipsychotics. WO2005016900A1 [2]. Lundbeck H. A/S. The clinical phase III programme commenced on zicronapine. 20 Jan 2011. [3]. Lundbeck H, A/S. Zicronapine shows significant positive data in clinical phase II in the treatment of patients with schizophrenia –planning for continued clinical work. Press release No. 392 18 December 2009. |
Zicronapine
CAS: 170381-16-5 F: C22H27ClN2 W: 354.92
Zicronapine is an antipsychotic medication with a strong pro-cognitive effect in animal models and the potential to trea
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.